HealthEquity Affirms FY2027 Adj EPS Guidance of $4.66-$4.73 vs $4.72 Est; Raises FY2027 Sales Guidance from $1.410B-$1.420B to $1.411B-$1.421B vs $1.416B Est
HealthEquity (NASDAQ:HQY) affirms FY2027 Adj EPS guidance from $4.66-$4.73 to $4.66-$4.73 vs $4.72 analyst estimate. Raises FY2027 sales outlook from $1.410 billion-$1.420 billion to $1.411 billion-$1.421 billion vs
HealthEquity kept its profit forecast the same but raised its sales forecast slightly. When a company raises sales guidance, it suggests they're confident people will buy more of their services.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.